Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

1.

Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment.

Chien CC, Wang HY, Wang JJ, Kan WC, Chien TW, Lin CY, Su SB.

Ren Fail. 2011;33(8):758-64. doi: 10.3109/0886022X.2011.599911. Epub 2011 Jul 22.

PMID:
21777176
[PubMed - indexed for MEDLINE]
2.

Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.

Sam AD 2nd, Morasch MD, Collins J, Song G, Chen R, Pereles FS.

J Vasc Surg. 2003 Aug;38(2):313-8.

PMID:
12891113
[PubMed - indexed for MEDLINE]
Free Article
3.

Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.

Chrysochou C, Power A, Shurrab AE, Husain S, Moser S, Lay J, Salama AD, Kalra PA.

Clin J Am Soc Nephrol. 2010 Mar;5(3):484-9. doi: 10.2215/CJN.06580909. Epub 2010 Jan 21.

PMID:
20093350
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The safety of gadolinium in patients with stage 3 and 4 renal failure.

Ergün I, Keven K, Uruç I, Ekmekçi Y, Canbakan B, Erden I, Karatan O.

Nephrol Dial Transplant. 2006 Mar;21(3):697-700. Epub 2005 Dec 2.

PMID:
16326736
[PubMed - indexed for MEDLINE]
Free Article
5.

Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.

Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J.

Invest Radiol. 2011 Sep;46(9):556-66. doi: 10.1097/RLI.0b013e31821a218a.

PMID:
21623212
[PubMed - indexed for MEDLINE]
6.

Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent.

Fujisaki K, Ono-Fujisaki A, Kura-Nakamura N, Komune N, Hirakawa N, Tsuruya K, Komune S, Iida M.

Clin Nephrol. 2011 Mar;75(3):251-4.

PMID:
21329636
[PubMed - indexed for MEDLINE]
7.

Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.

Erley CM, Bader BD, Berger ED, Tuncel N, Winkler S, Tepe G, Risler T, Duda S.

Nephrol Dial Transplant. 2004 Oct;19(10):2526-31. Epub 2004 Jul 27.

PMID:
15280530
[PubMed - indexed for MEDLINE]
Free Article
8.

Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.

Morabito S, Pistolesi V, Benedetti G, Di Roma A, Colantonio R, Mancone M, Sardella G, Cibelli L, Ambrosino M, Polistena F, Pierucci A.

J Nephrol. 2012 Nov-Dec;25(6):1098-107. doi: 10.5301/jn.5000101.

PMID:
22383347
[PubMed - indexed for MEDLINE]
9.

Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis.

Perazella MA.

Curr Drug Saf. 2008 Jan;3(1):67-75. Review.

PMID:
18690983
[PubMed - indexed for MEDLINE]
10.

Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.

Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F.

Circulation. 2012 Jun 26;125(25):3099-107. doi: 10.1161/CIRCULATIONAHA.111.085290. Epub 2012 May 16.

PMID:
22592896
[PubMed - indexed for MEDLINE]
Free Article
11.

Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients.

Van Linden A, Kempfert J, Rastan AJ, Holzhey D, Blumenstein J, Schuler G, Mohr FW, Walther T.

Eur J Cardiothorac Surg. 2011 Jun;39(6):835-42; discussion 842-3. doi: 10.1016/j.ejcts.2010.11.034. Epub 2010 Dec 24.

PMID:
21186126
[PubMed - indexed for MEDLINE]
12.

Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media.

Rees O, Agarwal SK.

Clin Radiol. 2010 Aug;65(8):636-41. doi: 10.1016/j.crad.2010.04.012. Epub 2010 Jun 11.

PMID:
20599066
[PubMed - indexed for MEDLINE]
13.

Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury.

Gok Oguz E, Kiykim A, Turgutalp K, Olmaz R, Ozhan O, Muslu N, Horoz M, Bardak S, Sungur MA.

Med Sci Monit. 2013 Nov 6;19:942-8. doi: 10.12659/MSM.889579.

PMID:
24193150
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience.

Chrysochou C, Buckley DL, Dark P, Cowie A, Kalra PA.

J Magn Reson Imaging. 2009 Apr;29(4):887-94. doi: 10.1002/jmri.21708. Review.

PMID:
19306428
[PubMed - indexed for MEDLINE]
15.

Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.

Cho A, Lee JE, Kwon GY, Huh W, Lee HM, Kim YG, Kim DJ, Oh HY, Choi HY.

Nephrol Dial Transplant. 2011 Nov;26(11):3496-501. doi: 10.1093/ndt/gfr094. Epub 2011 Mar 15.

PMID:
21406544
[PubMed - indexed for MEDLINE]
Free Article
16.

Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.

Li XM, Cong HL, Li TT, He LJ, Zhou YJ.

Chin Med J (Engl). 2011 Jul;124(14):2101-6.

PMID:
21933609
[PubMed - indexed for MEDLINE]
Free Article
17.

Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function.

Hoffmann U, Fischereder M, Reil A, Fischer M, Link J, Krämer BK.

Eur J Med Res. 2005 Apr 20;10(4):149-54.

PMID:
15946910
[PubMed - indexed for MEDLINE]
18.

Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.

Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.

Am J Kidney Dis. 2008 Jun;51(6):966-75. doi: 10.1053/j.ajkd.2007.12.036. Epub 2008 Mar 25.

PMID:
18501784
[PubMed - indexed for MEDLINE]
19.

Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs.

Elmståhl B, Nyman U, Leander P, Chai CM, Frennby B, Almén T.

Acad Radiol. 2004 Nov;11(11):1219-28.

PMID:
15561568
[PubMed - indexed for MEDLINE]
20.

Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y.

Heart. 2011 Nov;97(21):1753-7. doi: 10.1136/hrt.2010.218677. Epub 2011 May 20.

PMID:
21602521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk